CXCL8 and treatment resistant depression: This study extends our prior work to a disparate treatment modality and evaluates whether IL-8 is associated with treatment response in a different sample of TRD patients undergoing open label ketamine infusion, with evaluation of sex differences (n = 46; 17 females).